• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种人源单链Fv胞内抗体可阻断过表达的α-突触核蛋白的异常细胞效应。

A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein.

作者信息

Zhou Chun, Emadi Sharareh, Sierks Michael R, Messer Anne

机构信息

Wadsworth Center, New York State Department of Health, Albany, NY 12201, USA.

出版信息

Mol Ther. 2004 Dec;10(6):1023-31. doi: 10.1016/j.ymthe.2004.08.019.

DOI:10.1016/j.ymthe.2004.08.019
PMID:15564134
Abstract

alpha-Synuclein (alpha-syn) has been identified as the major component of Lewy bodies that characterize neurodegenerative synucleinopathies, including Parkinson's disease. Overexpression of alpha-syn, and prefibrillar alpha-syn oligomers, has been implicated in these pathologies; therefore, prevention of prefibril accumulation, and inhibition of other aberrant effects of overexpressed alpha-syn, could provide novel treatments. Here, we have selected a human single-chan Fv (scFv) antibody, D10, that binds human monomeric wild-type alpha-syn. We demonstrate, by retargeting assays and coimmunoprecipitation, that the D10 scFv is a specific and efficient intracellular antibody (intrabody). By transfecting the D10 scFv gene into an HEK 293 cell line that overexpresses wild-type alpha-syn, we show that the D10 intrabody stabilizes detergent-soluble monomeric alpha-syn and inhibits the formation of detergent-insoluble high-molecular-weight alpha-syn species. In addition, the D10 intrabody ameliorates the decreased cell adhesion that characterizes the alpha-syn-overexpressing cells. Given the important role of alpha-syn pathology, and the facility with which intrabodies can be further engineered in vitro, anti-alpha-syn intrabodies may represent novel molecular therapeutics for synucleinopathies, with implications for other neurodegenerative disorders caused by misfolded accumulated proteins.

摘要

α-突触核蛋白(α-syn)已被确定为路易小体的主要成分,路易小体是神经退行性突触核蛋白病(包括帕金森病)的特征性表现。α-syn的过度表达以及原纤维前体α-syn寡聚体与这些病理过程有关;因此,预防原纤维前体的积累以及抑制过度表达的α-syn的其他异常作用可能提供新的治疗方法。在这里,我们选择了一种人单链Fv(scFv)抗体D10,它能与人单体野生型α-syn结合。我们通过重新靶向分析和免疫共沉淀证明,D10 scFv是一种特异性且高效的细胞内抗体(胞内抗体)。通过将D10 scFv基因转染到过表达野生型α-syn的HEK 293细胞系中,我们发现D10胞内抗体可稳定去污剂可溶的单体α-syn,并抑制去污剂不溶的高分子量α-syn物种的形成。此外,D10胞内抗体改善了α-syn过表达细胞所特有的细胞黏附能力下降的情况。鉴于α-syn病理的重要作用以及胞内抗体可在体外进一步改造的便利性,抗α-syn胞内抗体可能代表了突触核蛋白病的新型分子疗法,对由错误折叠的积累蛋白引起的其他神经退行性疾病也有意义。

相似文献

1
A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein.一种人源单链Fv胞内抗体可阻断过表达的α-突触核蛋白的异常细胞效应。
Mol Ther. 2004 Dec;10(6):1023-31. doi: 10.1016/j.ymthe.2004.08.019.
2
Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.用人源单链抗体片段抑制α-突触核蛋白的聚集
Biochemistry. 2004 Mar 16;43(10):2871-8. doi: 10.1021/bi036281f.
3
Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells.细胞内寡聚α-突触核蛋白的靶向作用与清除可减轻其在哺乳动物细胞中的毒性。
Neurosci Lett. 2009 Jul 31;459(1):16-8. doi: 10.1016/j.neulet.2009.04.046. Epub 2009 Apr 24.
4
Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.钙蛋白酶对α-突触核蛋白的切割:在α-突触核蛋白纤维化和硝化形式降解中的潜在作用。
Biochemistry. 2005 May 31;44(21):7818-29. doi: 10.1021/bi047846q.
5
Antiapoptotic property of human alpha-synuclein in neuronal cell lines is associated with the inhibition of caspase-3 but not caspase-9 activity.人α-突触核蛋白在神经元细胞系中的抗凋亡特性与半胱天冬酶-3活性的抑制有关,而与半胱天冬酶-9活性无关。
J Neurochem. 2005 Jun;93(6):1542-50. doi: 10.1111/j.1471-4159.2005.03146.x.
6
Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.由A53Tα-突触核蛋白突变引起的家族性帕金森病中α-突触核蛋白和tau蛋白的纤维化
Exp Neurol. 2004 Jun;187(2):279-88. doi: 10.1016/j.expneurol.2004.01.007.
7
Synphilin in normal human brains and in synucleinopathies: studies with new antibodies.正常人脑及突触核蛋白病中的突触结合蛋白:使用新型抗体的研究
Acta Neuropathol. 2003 Feb;105(2):177-84. doi: 10.1007/s00401-002-0629-2. Epub 2002 Nov 12.
8
Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration.多巴胺类似物通过与α-突触核蛋白的氨基反应抑制α-突触核蛋白纤维化。对多巴胺能神经变性的影响。
FEBS J. 2005 Jul;272(14):3661-72. doi: 10.1111/j.1742-4658.2005.04792.x.
9
Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells.SH-SY5Y神经母细胞瘤细胞分化后α-突触核蛋白聚集加速。
Brain Res. 2004 Jul 2;1013(1):51-9. doi: 10.1016/j.brainres.2004.04.018.
10
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.针对突触核蛋白的新型抗体在路易体病中显示出丰富的纹状体病理改变。
Ann Neurol. 2002 Aug;52(2):205-10. doi: 10.1002/ana.10279.

引用本文的文献

1
Single-domain antibody-based protein degrader for synucleinopathies.基于单域抗体的神经核蛋白病蛋白降解剂。
Mol Neurodegener. 2024 May 31;19(1):44. doi: 10.1186/s13024-024-00730-y.
2
Single-Domain Antibody-Based Protein Degrader for Synucleinopathies.用于治疗突触核蛋白病的基于单域抗体的蛋白质降解剂
bioRxiv. 2024 Apr 30:2024.03.11.584473. doi: 10.1101/2024.03.11.584473.
3
Recombinant Antibody Fragments for Immunotherapy of Parkinson's Disease.用于帕金森病免疫治疗的重组抗体片段。
BioDrugs. 2024 Mar;38(2):249-257. doi: 10.1007/s40259-024-00646-5. Epub 2024 Jan 27.
4
Anti-tau intrabodies: From anti-tau immunoglobulins to the development of functional scFv intrabodies.抗tau细胞内抗体:从抗tau免疫球蛋白到功能性单链抗体片段细胞内抗体的研发
Mol Ther Methods Clin Dev. 2023 Nov 14;31:101158. doi: 10.1016/j.omtm.2023.101158. eCollection 2023 Dec 14.
5
Tau-targeting therapies for Alzheimer disease: current status and future directions.针对阿尔茨海默病的靶向 Tau 治疗:现状与未来方向。
Nat Rev Neurol. 2023 Dec;19(12):715-736. doi: 10.1038/s41582-023-00883-2. Epub 2023 Oct 24.
6
Sex-Specific Multiparameter Blood Test for the Early Diagnosis of Alzheimer's Disease.用于阿尔茨海默病早期诊断的性别特异性多参数血液检测。
Int J Mol Sci. 2022 Dec 10;23(24):15670. doi: 10.3390/ijms232415670.
7
Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools.利用化学生物学工具解析神经退行性疾病中淀粉样蛋白的结构与形成
Front Chem. 2022 May 12;10:886382. doi: 10.3389/fchem.2022.886382. eCollection 2022.
8
Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly.靶向 tau 仅细胞外可能不如靶向细胞内外都更有效。
Semin Cell Dev Biol. 2022 Jun;126:125-137. doi: 10.1016/j.semcdb.2021.12.002. Epub 2021 Dec 9.
9
Lentiviral Vectors Expressing Chimeric NEDD4 Ubiquitin Ligases: An Innovative Approach for Interfering with Alpha-Synuclein Accumulation.慢病毒载体表达嵌合 NEDD4 泛素连接酶:一种干扰 α-突触核蛋白积累的创新方法。
Cells. 2021 Nov 21;10(11):3256. doi: 10.3390/cells10113256.
10
Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review).α-突触核蛋白在胃肠道微生物组失调相关帕金森病进展中的作用(综述)。
Mol Med Rep. 2021 Oct;24(4). doi: 10.3892/mmr.2021.12374. Epub 2021 Aug 20.